Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study.
Oral therapy approved for multiple sclerosis.
Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity.
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses.
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.
Catechol-O-Methyltransferase Val158Met Polymorphism (rs4680) Is Associated With Pain in Multiple Sclerosis.
The influence of immunomodulatory treatment on the clinical course of multiple sclerosis.
[Clinical features of 314 patients with relapsing-remitting multiple sclerosis].
Long-term epidemiology of multiple sclerosis in the Northern Seville District.
Polysialic acid modification of the synaptic cell adhesion molecule SynCAM 1 in human embryonic stem cell-derived oligodendrocyte precursor cells.
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder.
The Case | The young philosopher with multiple sclerosis and proteinuria.
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis"
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
The quality of primary health care for chronically ill patients: a cross-sectional study.
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
Serum vitamin d levels in Indian patients with multiple sclerosis.
Pages
« first
‹ previous
…
643
644
645
646
647
648
649
650
651
…
next ›
last »